Cedric Francois - Jan 28, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Executive Officer, Director
Signature
/s/David Watson, attorney-in-fact for Cedric Francois
Stock symbol
APLS
Transactions as of
Jan 28, 2022
Transactions value $
-$78,106
Form type
4
Date filed
2/1/2022, 05:00 PM
Previous filing
Jan 25, 2022
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$78.1K -2.02K -0.15% $38.59 1.34M Jan 28, 2022 Direct F1
holding APLS Common Stock 234K Jan 28, 2022 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.
F2 The securities are held by The Francois-DuBois Educational Trust (the "Trust"), for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.